These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20887719)

  • 1. Direct tissue analysis by MALDI-TOF mass spectrometry in human hepatocellular carcinoma.
    Han EC; Lee YS; Liao WS; Liu YC; Liao HY; Jeng LB
    Clin Chim Acta; 2011 Jan; 412(3-4):230-9. PubMed ID: 20887719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histology-directed matrix-assisted laser desorption/ionization analysis reveals tissue origin and p53 status of primary liver cancers.
    Jeon YE; Lee SC; Paik SS; Lee KG; Jin SY; Kim HR; Yoo CW; Park HM; Han SY; Choi DH; Kim HK
    Pathol Int; 2011 Aug; 61(8):449-55. PubMed ID: 21790858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas.
    Poté N; Alexandrov T; Le Faouder J; Laouirem S; Léger T; Mebarki M; Belghiti J; Camadro JM; Bedossa P; Paradis V
    Hepatology; 2013 Sep; 58(3):983-94. PubMed ID: 23553687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the Golgi proteome of hepatocellular carcinoma with that of the adjacent non-tumor tissues].
    Xiao Z; Yi YF; He TT; Li YQ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):23-6. PubMed ID: 20128964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALDI imaging-based classification of hepatocellular carcinoma and non-malignant lesions in fibrotic liver tissue.
    Marquardt C; Tolstik T; Bielecki C; Kaufmann R; Crecelius AC; Schubert US; Settmacher U; Stallmach A; Dirsch O
    Z Gastroenterol; 2015 Jan; 53(1):33-9. PubMed ID: 25594705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
    Huang C; Fan J; Zhou J; Liu YK; Cui JF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
    Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
    Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
    Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
    Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates.
    Rainer M; Muhammad NU; Huck CW; Feuerstein I; Bakry R; Huber LA; Gjerde DT; Zou X; Qian H; Du X; Wei-Gang F; Ke Y; Bonn GK
    Rapid Commun Mass Spectrom; 2006; 20(19):2954-60. PubMed ID: 16953521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients].
    Huang C; Fan J; Zhou J; Liu YK; Cui JF; Kang XN; Yang PY; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):781-5. PubMed ID: 15949388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of human hepatocellular carcinoma cell-targeted protein cages.
    Toita R; Murata M; Tabata S; Abe K; Narahara S; Piao JS; Kang JH; Hashizume M
    Bioconjug Chem; 2012 Jul; 23(7):1494-501. PubMed ID: 22621213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis.
    Le Faouder J; Laouirem S; Chapelle M; Albuquerque M; Belghiti J; Degos F; Paradis V; Camadro JM; Bedossa P
    J Proteome Res; 2011 Aug; 10(8):3755-65. PubMed ID: 21675781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.
    Orvisky E; Drake SK; Martin BM; Abdel-Hamid M; Ressom HW; Varghese RS; An Y; Saha D; Hortin GL; Loffredo CA; Goldman R
    Proteomics; 2006 May; 6(9):2895-902. PubMed ID: 16586431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
    Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
    Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.